Grünenthal, Australian

Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect

18.03.2026 - 01:34:54 | prnewswire.co.uk

Grünenthal Group Australia Germany

| Instagram: grunenthal

About Clinect
Clinect is part of the EBOS Group the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. Clinect supports patients in Australia and New Zealand with established and innovative products via strategic partnering relationships. Clinect together with its affiliates, will market and distribute the product in Australia.



Media Contacts

Grünenthal

Maren Thurow

Head Global Communication
Phone: +44 7917 196855
Maren.Thurow@grunenthal.com

Clinect
John Bennetts
Head of Communication and Corporate Affairs
Phone: +61 498 000 897
John.Bennetts@ebosgroup.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/grunenthal-licenses-exclusive-australian-rights-to-qutenza-to-clinect-302695471.html

So schätzen die Börsenprofis Aktien ein!

<b>So schätzen die Börsenprofis   Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
boerse | 68764457 |